ライフサイエンスコーパス: leucine-rich repeat

1 domain, and a variable number of C-terminal leucine-rich repeats.

2 ous work has shown that Elfn1 (extracellular leucine rich repeat and fibronectin Type III domain cont

3 s nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 1 (NLRP1

4 o a pair of amino acids, 106 and 156, in the leucine-rich repeat and central domains and show these m

5 me of Ewing and showed unexpectedly that the leucine-rich repeat and Ig domain protein 1 (LINGO1) is

6 Leucine-rich repeat and Ig-like domain-containing Nogo r

7 We previously demonstrated that leucine-rich repeat and Ig-like domain-containing Nogo r

8 LRIG1 (leucine-rich repeat and immunoglobulin-like domain conta

9 d nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain containing 3 (NRLP3

10 ng and oligomerization domain-like receptor, leucine-rich repeat and pyrin domain-containing 3 (NLRP3

11 nase kinases (MKKs) and rodent NLRP1B (NACHT leucine-rich repeat and pyrin domain-containing protein

12 ses an additional 33 amino acids between the leucine-rich repeats and carboxy-terminal low-complexity

13 tion is linked to carcinogenesis, and Lrig1 (leucine-rich repeats and Ig-like domains 1) marks a dist

14 The earring-shaped NLRP3 consists of curved leucine-rich-repeat and globular NACHT domains, and the

15 ere, we show that nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein

16 , nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin protein 3 complex, CASP1,

17 d nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin protein 3 complex.

18 NLRs (nucleotide-binding domain and leucine-rich repeats) belong to a large family of cytopl

19 orrelated with reduced expression of LRRC26 (leucine rich repeat containing 26), the gamma subunit ma

20 d activation of pathways of beta-catenin and leucine rich repeat containing G protein-coupled recepto

21 Nucleotide-binding oligomerization domain, leucine rich repeat containing X1 (NLRX1) is a unique NL

22 ate mapping of nucleotide-binding domain and leucine-rich repeat containing (NLR) genes.

23 VASP, extended-synaptotagmin 2 [ESYT2], and leucine-rich repeat containing 15 [LRRC15]), and "isomer

24 nical events except stroke, the LRRC3B gene (leucine-rich repeat containing 3B) with myocardial infar

25 Leucine-rich repeat containing 8A (LRRC8A) is an ubiquit

26 showing that multimers derived from LRRC8A (leucine-rich repeat containing 8A) gene are structural c

27 Here, we report that the leucine-rich repeat containing family 8 (LRRC8)/volume-r

28 aR1 as a stereoselective activator for human leucine-rich repeat containing G protein-coupled recepto

29 Leucine-rich repeat containing G-protein-coupled recepto

30 tly characterized nucleotide-binding domain, leucine-rich repeat containing protein (NLR) that negati

31 Here, we report that leucine-rich repeat containing protein 25 (LRRC25) is a

32 xplore the role of nucleotide-binding domain leucine-rich repeat containing receptor family member NL

33 re the role of the nucleotide-binding domain leucine-rich repeat containing receptor family member Nl

34 he role of the nucleotide-binding domain and leucine-rich repeat containing receptor NLRP10 in diseas

35 Nucleotide-binding, leucine-rich repeat containing X1 (NLRX1) is a mitochond

36 (CITA), NLRC5 [nucleotide-binding domain and leucine-rich repeats containing (NLR) family, caspase ac

37 n VRACs was obtained by the discovery of the leucine-rich repeats containing 8A (LRRC8A) gene.

38 between 2 candidate genes, EMSY and LRRC32 (leucine-rich repeat-containing 32) but the functional me

39 (i.e. SEC61) and ER proteins (ribophorin I, leucine-rich repeat-containing 59 (LRRC59), and SEC62) p

40 ly defined, revealing that it belongs to the leucine-rich repeat-containing 8 (LRRC8) protein family.

41 The recent identification of Leucine-Rich Repeat-Containing 8 (LRRC8A-E) proteins as

42 In mice, specific nucleotide-binding domain, leucine-rich repeat-containing family, apoptosis inhibit

43 IPs) activate the nucleotide-binding domain, leucine-rich repeat-containing family, CARD domain-conta

44 , we report a pivotal role for the R-spondin/leucine-rich repeat-containing G protein-coupled recepto

45 Leucine-rich repeat-containing G protein-coupled recepto

46 rkers, epithelial cell adhesion molecule and leucine-rich repeat-containing G protein-coupled recepto

47 lycan motif common to all bacteria, supports leucine-rich repeat-containing G protein-coupled recepto

48 We show here that the orphan receptor leucine-rich repeat-containing G protein-coupled recepto

49 Human organoids derived from leucine-rich repeat-containing G protein-coupled recepto

50 WNT/beta-catenin signaling in cells lacking leucine-rich repeat-containing G-protein coupled recepto

51 ciated CpG was cg03566881 located within the leucine-rich repeat-containing G-protein coupled recepto

52 ified Wnt environment leads to activation of leucine-rich repeat-containing G-protein coupled recepto

53 Leucine-rich repeat-containing G-protein coupled recepto

54 rapidly growing adenomas containing LGR5(+) (leucine-rich repeat-containing G-protein coupled recepto

55 inct molecular markers, including Norrin and leucine-rich repeat-containing G-protein-coupled recepto

56 Here we show that the leucine-rich repeat-containing G-protein-coupled recepto

57 Herein we report that leucine-rich repeat-containing G-protein-coupled recepto

58 re we report that the abundant expression of leucine-rich repeat-containing G-protein-coupled recepto

59 R-spondins (Rspos) are endogenous ligands of leucine-rich repeat-containing G-protein-coupled recepto

60 through the transcriptional up-regulation of leucine-rich repeat-containing GPCR 4 (Lgr4).

61 The fourth member of the leucine-rich repeat-containing GPCR family (LGR4, freque

62 o the B-family (or secretin-like), and 2 are leucine-rich repeat-containing GPCRs.

63 d nucleotide-binding oligomerization domain, leucine-rich repeat-containing protein (NLRP) 3 and pro-

64 cing mRNA expression of the BK gamma subunit leucine-rich repeat-containing protein 26 (LRRC26) and i

65 Here, we report a DNA repair suppressor, leucine-rich repeat-containing protein 31 (LRRC31), that

66 These channels are formed by leucine-rich repeat-containing protein 8 (LRRC8) family

67 ator of reactive oxygen species (NRROS) is a leucine-rich repeat-containing protein that uniquely ass

68 are sensed by nucleotide binding domain and leucine-rich repeat-containing proteins (NLRs), which tr

69 a member of the LRIG family of transmembrane leucine-rich repeat-containing proteins, is a negative r

70 Nucleotide-binding and leucine-rich repeat-containing receptors (NLRs) encompas

71 eotide-binding oligomerization domain (Nod), leucine-rich repeat-containing receptors (NLRs), and pyr

72 or cell surface molecules and identified the leucine-rich repeat-containing transmembrane protein kno

73 ionships between relaxin family peptides and leucine-rich repeat-containing, G protein-coupled recept

74 , Epithelial cell adhesion molecule (EpCAM), Leucine-rich repeated-containing G-protein coupled recep

75 ng on the NLRX1 (nucleotide-binding, lots of leucine-rich repeats-containing protein member X1)-TUFM

76 the contributions of two recently identified leucine-rich-repeat-containing (LRRC) regulatory gamma s

77 Pm5e encodes a nucleotide-binding domain leucine-rich-repeat-containing (NLR) protein.

78 activation of the nucleotide-binding domain, leucine-rich-repeat-containing receptor (NLR), pyrin-dom

79 Five nucleotide binding leucine-rich repeat contigs distinguished resistant and

80 1 component (S519C16) of S519 with the first leucine-rich repeat domain (L1) of the insulin receptor.

81 alpha dissociation and unfolds the GPIbalpha leucine-rich repeat domain (LRRD) and juxtamembrane mech

82 Scribble consists of a leucine-rich repeat domain and four PDZ domains, with th

83 through two identified binding sites in its leucine-rich repeat domain and regulating collagen fibri

84 The tyrosine-sulfated domain and the leucine-rich repeat domain both bound to three specific

85 The isolated leucine-rich repeat domain inhibited the fibril formatio

86 n asymmetric dimer bridged by the N-terminal leucine-rich repeat domain of ANP32A.

87 nt interface specifically formed between the leucine-rich repeat domain of FBXL2 and PTAR1, which unm

88 flammasome required NEK7, which bound to the leucine-rich repeat domain of NLRP3 in a kinase-independ

89 tartan (trn), which encodes a transmembrane leucine-rich repeat domain protein that mediates cell-ce

90 domain gene product containing an N-terminal leucine-rich repeat domain, followed by a likely posttra

91 this study, we show that Scrib, through its leucine-rich repeat domain, forms a complex in vivo with

92 e plant can evolve nucleotide-binding domain-leucine-rich repeat domain-containing proteins to recogn

93 Both possess conserved leucine rich repeat domains (LRR) as proposed sites of m

94 Receptor kinases with extracellular leucine-rich repeat domains (LRR-RKs) form the largest g

95 Nucleotide binding- and leucine-rich repeat domains of NLRC4, but not its CARD,

96 Moreover, the leucine-rich repeat domains, and specifically four amino

97 in NLRP1, encoding Nucleotide-Binding Domain Leucine-Rich Repeat Family Pyrin Domain-Containing 1.

98 tf13, defining it as an F-box protein of the leucine-rich-repeat family, and demonstrates how a novel

99 hibitor Flightless-1 and its binding partner leucine-rich repeat flightless-interacting protein 2.

100 The NLRs or NBS-LRRs (nucleotide-binding, leucine-rich-repeat) form the largest resistance gene fa

101 We show that Drosophila leucine-rich repeat G protein-coupled receptor 3 (Lgr3)

102 length, with the most significant being the leucine rich repeat gene, LRRC34 (p = 3.69 x 10(-18)).

103 d genes included 639 nucleotide-binding site leucine-rich repeat genes (NBS-LRRs), 290 receptor-like

104 and 56% (343) of 616 nucleotide-binding site-leucine-rich repeat genes harbored at least one Tnt1 ins

105 Nucleotide-binding and leucine-rich repeat immune receptors (NLRs) provide resi

106 ponse proteins, including nucleotide-binding leucine-rich repeat immune receptors, oxidative and DNA

107 eptor-related alpha, flightless-1 (FLII) and leucine-rich-repeat-(in FLII)-interacting-protein-1 as a

108 h NLRP10 is the only NLR protein lacking the leucine rich repeats, it has been implicated in multiple

109 The Leucine rich repeat kinase 2 (LRRK2) gene is genetically

110 Leucine rich repeat kinase 2 (LRRK2) is an enigmatic enz

111 Pase domain Ras of complex proteins (ROC) of leucine rich repeat kinase 2 (LRRK2) result in an abnorm

112 The LRRK2 gene, coding for leucine rich repeat kinase 2 (LRRK2), is a key player in

113 Leucine rich repeat kinase 2 is a complex enzyme with bo

114 The leucine-rich repeat kinase (LRRK)-2 protein contains non

115 Mutations in leucine-rich repeat kinase 2 (LRRK2) and alpha-synuclein

116 Mutations in the gene encoding for leucine-rich repeat kinase 2 (LRRK2) are a common cause

117 Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with

118 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common

119 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common

120 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common

121 Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most freque

122 Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) can cause Parkinson

123 Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dom

124 Mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset, a

125 Mutations in leucine-rich repeat kinase 2 (LRRK2) contribute to devel

126 Leucine-rich repeat kinase 2 (LRRK2) encodes a complex p

127 Mutations in the kinase domain of leucine-rich repeat kinase 2 (LRRK2) follow Parkinson's

128 Leucine-rich repeat kinase 2 (LRRK2) G2019S is a relativ

129 Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most c

130 ortem PD patients' substantia nigra; and (b) leucine-rich repeat kinase 2 (LRRK2) gene identified pat

131 Genetic variation in the leucine-rich repeat kinase 2 (LRRK2) gene is associated

132 Parkinson's disease gene leucine-rich repeat kinase 2 (LRRK2) has been implicated

133 Leucine-rich repeat kinase 2 (LRRK2) has been linked to

134 The Parkinson's disease (PD)-associated gene leucine-rich repeat kinase 2 (LRRK2) has been studied ex

135 Multiple missense mutations in Leucine-rich repeat kinase 2 (LRRK2) have been linked to

136 emical studies implicate alpha-synuclein and leucine-rich repeat kinase 2 (LRRK2) in late-onset PD.

137 The G2019S mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause o

138 The G2019S mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause o

139 Leucine-rich repeat kinase 2 (LRRK2) is a large multidom

140 Leucine-rich repeat kinase 2 (LRRK2) is a large multidom

141 Leucine-rich repeat kinase 2 (LRRK2) is a large, multido

142 Leucine-rich repeat kinase 2 (LRRK2) is a large, multido

143 Leucine-rich repeat kinase 2 (LRRK2) is a promising ther

144 Leucine-rich repeat kinase 2 (LRRK2) is the most commonl

145 Mutations in leucine-rich repeat kinase 2 (LRRK2) lead to late-onset,

146 Leucine-rich repeat kinase 2 (LRRK2) mutation 6055G-->A

147 A broad role for leucine-rich repeat kinase 2 (LRRK2) mutations in famili

148 We investigated the role of leucine-rich repeat kinase 2 (LRRK2) on lysosome biology

149 tions in Park8, encoding for the multidomain Leucine-rich repeat kinase 2 (LRRK2) protein, comprise t

150 We found that the Parkinson's disease gene, leucine-rich repeat kinase 2 (LRRK2), has an unexpected

151 unknown, but several genetic loci, including leucine-rich repeat kinase 2 (LRRK2), have been identifi

152 Mutations in leucine-rich repeat kinase 2 (LRRK2), such as G2019S, ar

153 encoding a-synuclein (SNCA), tau (MAPT), and leucine-rich repeat kinase 2 (LRRK2).

154 al effects of a common PD-linked mutation of leucine-rich repeat kinase 2 in the mouse hippocampus, a

155 1 exacerbated death of PQ-exposed cells in a leucine-rich repeat kinase 2-mediated manner.

156 Inhibition of leucine-rich repeat kinase using PFE360 failed to rescue

157 st these factors using mutant LRRK2(R1441G) (leucine-rich-repeat-kinase-2) knockin mice.

158 cleotide variant (SNV) within the C-terminal leucine rich repeat (LRR) domain is responsible for the

159 On examples of proteins with Leucine Rich Repeat (LRR) domains and other solenoids li

160 a domain swap and point mutations, that the leucine-rich repeat (LRR) 5 region comprises an importan

161 We recently identified the leucine-rich repeat (LRR) adhesion protein, trophoblast

162 most N-terminal domain of Reck binds to the leucine-rich repeat (LRR) and immunoglobulin (Ig) domain

163 All sera and 9/11 CSFs bound both the leucine-rich repeat (LRR) and the epitempin repeat (EPTP

164 SHR4z has significant homology to the short leucine-rich repeat (LRR) domain of SOMATIC EMBRYOGENESI

165 In addition to its leucine-rich repeat (LRR) domain that has been previousl

166 is repressed by a flanking substrate-binding leucine-rich repeat (LRR) domain when substrate is absen

167 Leucine-rich repeat (LRR) domains are evolutionarily con

168 PI)-ANCHORED PROTEINS (LLG) complexes, or by leucine-rich repeat (LRR) extensin proteins (LRXs).

169 In particular, leucine-rich repeat (LRR) genes make the largest contrib

170 CCR4s contain N-terminal leucine-rich repeat (LRR) motifs that interact with CAF1

171 As proof-of-concept, we used a leucine-rich repeat (LRR) protein binder, called a repeb

172 port isolation and identification of a novel Leucine-Rich Repeat (LRR) protein that directly interact

173 Plant nucleotide-binding (NB) leucine-rich repeat (LRR) receptor (NLR) proteins functi

174 mutants encodes a receptor lacking a single leucine-rich repeat (LRR) within its N-terminus.

175 The nucleotide-binding-domain (NBD)-and leucine-rich repeat (LRR)-containing (NLR) family, pyrin

176 n in the nucleotide-binding domain (NBD) and leucine-rich repeat (LRR)-containing (NLR) inflammasome

177 his study, we identified LRRC25, a member of leucine-rich repeat (LRR)-containing protein family, as

178 subgroup of nucleotide-binding domain (NBD), leucine-rich repeat (LRR)-containing proteins (NLRs) att

179 After ligand perception, many leucine-rich repeat (LRR)-containing PRRs interact with

180 ated promoter::GUS transgenic plants for all leucine-rich repeat (LRR)-RLKs in Arabidopsis and analyz

181 eotide-binding (NB) domain, and a C-terminal leucine-rich repeat (LRR).

182 I), an actin-binding protein that contains a leucine-rich-repeat (LRR), which binds R-ras and may reg

183 NLR (nucleotide-binding [NB] leucine-rich repeat [LRR] receptor) proteins are critica

184 NLRs (nucleotide-binding domain [NBD] leucine-rich repeat [LRR]-containing proteins) exhibit d

185 Herein, we introduce leucine-rich repeats (LRRs) and calponin homology contai

186 scaffold protein composed almost entirely by leucine-rich repeats (LRRs) and having an N-terminal reg

187 d cytoplasmic protein that contains multiple leucine-rich repeats (LRRs) and interacts with integrin-

188 c screen for genes encoding proteins bearing leucine-rich repeats (LRRs) and nucleotide-binding domai

189 usly expressed transmembrane protein with 17 leucine-rich repeats (LRRs) at its C-terminal end and is

190 with its substrate C-MYC via its C-terminal leucine-rich repeats (LRRs) domain.

191 idues on the concave surfaces of neighboring leucine-rich repeat modules assists in stabilizing the o

192 Several plant nucleotide-binding, leucine-rich repeat (NB-LRR) immune receptors carry fusi

193 Nucleotide-binding leucine-rich repeat (NB-LRR, or NLR) receptors mediate p

194 The cytosolic nucleotide binding site-leucine rich repeat (NBS-LRR) resistance proteins of pla

195 Plant nucleotide-binding leucine-rich repeat (NLR) disease resistance proteins re

196 NLRC4 [nucleotide-binding domain and leucine-rich repeat (NLR) family, caspase recruitment do

197 ost most of the conserved nucleotide-binding leucine-rich repeat (NLR) genes that are known to be inv

198 A nucleotide-binding, leucine-rich repeat (NLR) immune receptor gene was isola

199 Plant nucleotide-binding leucine-rich repeat (NLR) immune receptors activate cell

200 Plant nucleotide binding/leucine-rich repeat (NLR) immune receptors are activated

201 Nucleotide-binding leucine-rich repeat (NLR) immune receptors play a critic

202 Plant intracellular nucleotide binding leucine-rich repeat (NLR) immune receptors play critical

203 Plant nucleotide-binding leucine-rich repeat (NLR) immune receptors recognize pat

204 e of four genes encoding nucleotide-binding, leucine-rich repeat (NLR) immune receptors.

205 that are monitored by nucleotide-binding and leucine-rich repeat (NLR) immune receptors.

206 stance genes encoding nucleotide-binding and leucine-rich repeat (NLR) intracellular immune receptor

207 in the gene encoding the nucleotide binding, leucine-rich repeat (NLR) protein NbZAR1.

208 autoimmunity through the nucleotide-binding leucine-rich repeat (NLR) protein SUMM2 and the MAPK kin

209 ition of XopQ 1 (Roq1), a nucleotide-binding leucine-rich repeat (NLR) protein with a Toll-like inter

210 ical to VICTR, encoding a nucleotide-binding leucine-rich repeat (NLR) protein(3).

211 RPS5, a nucleotide-binding leucine-rich repeat (NLR) protein, is activated by the p

212 med RPS5, which encodes a nucleotide-binding leucine-rich repeat (NLR) protein.

213 Nucleotide-binding domain and leucine-rich repeat (NLR) proteins are well-known for th

214 Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable plants to reco

215 Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable the immune sys

216 Nucleotide-binding domain leucine-rich repeat (NLR) proteins function as cytosolic

217 stance genes encoding for nucleotide-binding leucine-rich repeat (NLR) proteins hampers their predict

218 Nucleotide binding site leucine-rich repeat (NLR) proteins of the plant innate i

219 Nucleotide-binding leucine-rich repeat (NLR) proteins play critical roles i

220 Nucleotide-binding leucine-rich repeat (NLR) proteins serve as immune recep

221 nce is often conferred by nucleotide-binding leucine-rich repeat (NLR) proteins, intracellular immune

222 nes encode intracellular nucleotide-binding, leucine-rich repeat (NLR) proteins.

223 ivation of the nucleotide-binding domain and leucine-rich repeat (NLR) pyrin family domain 3 (NLRP3)

224 coding a coiled-coil nucleotide binding site Leucine-rich repeat (NLR) receptor protein that was alte

225 ted by intracellular nucleotide-binding site leucine-rich repeat (NLR) receptor proteins.

226 r proteins of the nucleotide-binding domain, leucine-rich repeat (NLR) superfamily to detect many typ

227 Nucleotide-binding domain and leucine-rich repeat (NLR)-containing proteins in plants

228 OUS MIX2 (DM2) nucleotide-binding domain and leucine-rich repeat (NLR)-encoding locus in A. thaliana.

229 existing phytohormone and nucleotide-binding-leucine-rich-repeat (NLR) networks, to regulate immunity

230 ique among the nucleotide-binding-domain and leucine-rich-repeat (NLR) proteins in its mitochondrial

231 rs designated "nucleotide-binding domain and leucine-rich repeat" (NLR) proteins that translate patho

232 Nucleotide binding site-leucine rich repeats (NLRs), receptor-like kinases (RLKs

233 epigenetic regulation of nucleotide-binding leucine rich repeat or Nod-Like Receptor (NLR) genes as

234 Pleckstrin homology domain and leucine rich repeat protein phosphatase 1 (PHLPP1) is a

235 s a coiled-coil, nucleotide-binding site and leucine-rich repeat protein (CNL).

236 Ptr1 candidates to eight nucleotide-binding leucine-rich repeat protein (NLR)-encoding genes.

237 r matrix component proline/arginine-rich end leucine-rich repeat protein (PRELP) is a novel antibacte

238 he EMT inducer Twist1 by enhancing F-box and leucine-rich repeat protein 14 (FBXL14)-mediated polyubi

239 F-box and leucine-rich repeat protein 16 (FBXL16) is a poorly stud

240 Here, we show that Fbxl17 (F-box and leucine-rich repeat protein 17) targets Sufu for proteol

241 ISLR2 (immunoglobulin superfamily containing leucine-rich repeat protein 2) and STRA6 (stimulated by

242 is capable of triggering NLRP3 (NLR-family, leucine-rich repeat protein 3) inflammasome activation a

243 usly unrecognized role for the transmembrane leucine-rich repeat protein Lapsyn in regulating mng dev

244 We show that the phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP) downstre

245 n this study, we demonstrated that PH domain leucine-rich repeat protein phosphatase (PHLPP), a novel

246 we identified pleckstrin homology domain and leucine-rich repeat protein phosphatase 1 (PHLPP1) as a

247 that deletion of the gene encoding PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) prote

248 Pleckstrin homology (PH) domain and leucine-rich repeat protein phosphatase 1 (Phlpp1) regul

249 co-localization of Akt and PHLPP1 (PH domain leucine-rich repeat protein phosphatase isoform 1), a Se

250 iled multi-genome-derived nucleotide-binding leucine-rich repeat protein repertoire involved in disea

251 1.2 encodes a coiled-coil nucleotide-binding leucine-rich repeat protein that in addition to potato a

252 rice gene Xa1, encoding a nucleotide-binding leucine-rich repeat protein, confers resistance against

253 rod bipolar cell terminals is regulated by a leucine-rich repeat protein, LRRTM4.

254 c map of the entire folding landscape of the leucine-rich repeat protein, pp32 (Anp32), obtained by c

255 Nucleotide binding domain and leucine-rich repeat proteins (NLRs) are important recept

256 Nucleotide-binding leucine-rich repeat proteins (NLRs) serve as intracellul

257 enes encoding coiled-coil nucleotide-binding leucine-rich repeat proteins designated CNL3 and CNL13.

258 ns, immunoglobulin superfamily proteins, and leucine-rich repeat proteins, as well as their associate

259 s in the expansion of nucleotide-binding and leucine-rich-repeat proteins (NLRs), the major disease-r

260 ulators of the nucleotide-binding domain and leucine-rich repeat pyrin domain containing 3 inflammaso

261 and activate the nucleotide-binding domain, leucine-rich repeat pyrin domain-containing 3 (NLRP3) in

262 1 does so via the nucleotide-binding domain, leucine-rich repeat, pyrin domain containing protein 3 (

263 es with pyrin and nucleotide-binding domain, leucine-rich repeat/pyrin domain-containing 3.

264 Here, we show that leucine rich repeat receptor and nogo-interacting protei

265 ovo assembly of complete nucleotide-binding, leucine-rich repeat receptor (NLR) genes, their regulato

266 Floral abscission is controlled by the leucine-rich repeat receptor kinase (LRR-RK) HAESA and t

267 The leucine-rich repeat receptor kinases (LRR-RK) FLS2 and E

268 Plants use leucine-rich repeat receptor kinases (LRR-RKs) to sense

269 by direct binding to the membrane-localized leucine-rich repeat receptor kinases, PEP RECEPTOR1 (PEP

270 ant responses, we identified a corresponding leucine-rich repeat receptor, termed INR, specific to se

271 roid insensitive 1 (BRI1) is a member of the leucine-rich repeat receptor-like kinase family.

272 n of the plasma membrane-localized, atypical leucine-rich repeat receptor-like kinase POLLEN-SPECIFIC

273 d to a shoot receptor complex containing the leucine-rich repeat receptor-like kinase SUNN, triggerin

274 SCM, a leucine-rich repeat receptor-like kinase, is required fo

275 liana plant architecture, ERECTA, encoding a leucine-rich repeat receptor-like kinase.

276 st to G protein activation in animals, plant leucine-rich repeat receptor-like kinases (LRR RLKs), no

277 nases expanded massively in land plants, and leucine-rich repeat receptor-like kinases (LRR-RLK) cons

278 Cell signaling pathways mediated by leucine-rich repeat receptor-like kinases (LRR-RLKs) are

279 In embryophytes, the leucine-rich repeat receptor-like kinases (LRR-RLKs) are

280 the CLE family interacting with CLAVATA1 and leucine-rich repeat receptor-like kinases (LRR-RLKs).

281 Both pathways involve leucine-rich repeat receptor-like kinases acting in shoo

282 ts in Arabidopsis, and identified HPCA1 as a leucine-rich-repeat receptor kinase belonging to a previ

283 Here we demonstrate that the leucine-rich-repeat receptor Tartan and the teneurin Ten

284 Here we report FASCIATED EAR3 (FEA3), a leucine-rich-repeat receptor that functions in stem cell

285 s, RGF1 INSENSITIVEs (RGIs), a clade of five leucine-rich-repeat receptor-like kinases, in promoting

286 Nucleotide-binding leucine-rich repeat receptors (NLRs) monitor the plant i

287 ction using intracellular nucleotide-binding leucine-rich repeat receptors (NLRs) that directly or in

288 innate immunity relies on nucleotide binding leucine-rich repeat receptors (NLRs) that recognize path

289 i, including proteins putatively involved in leucine-rich repeat recognition activity, second messeng

290 Nucleotide-binding site leucine-rich repeat resistance genes (NLRs) allow plants

291 ike mechanism that employs flanking variable leucine-rich repeat sequences as templates in associatio

292 cluding genes putatively encoding NB-ARC and leucine-rich repeat sequences, protein kinases and defen

293 PR library targeting the immunity-associated leucine-rich repeat subfamily XII genes, heritable mutat

294 members of the immunoglobulin, cadherin, and leucine-rich repeat superfamilies.

295 f TIR domain-containing, nucleotide binding, leucine-rich repeat (TNL) immune receptors.

296 Leucine rich repeat transmembrane (LRRTM) proteins are s

297 ds to two transcellular ligands: fibronectin leucine-rich repeat transmembrane proteins (FLRTs) and t

298 ules neurexin-1beta, neuroligin-1 (Nlg1) and leucine-rich-repeat transmembrane protein 2 (LRRTM2) in

299 LAT); B-cell CLL/lymphoma 11B (BCL11B); RGD, leucine-rich repeat, tropomodulin domain, and proline-ri

300 hocyte receptors (VLRs) composed of variable leucine-rich repeats, which are differentially expressed